Changhe Qi

Changhe Qi has extensive experience in medicinal chemistry. Changhe began their career in 2007 as a Principal Scientist I at Shanghai Chempartner, where they were promoted to Senior Research Scientist I, II, and III. In 2015, they moved to AstraZeneca as a Senior Scientist, Medicinal Chemistry. In 2017, they were hired by Dizal Pharma as a Director, Medicinal Chemistry, and in 2021 they were appointed as Vice President, Medicinal Chemistry at TandemAI.

Changhe Qi obtained a PhD in Organic Chemistry from the Changchun Institute of Applied Chemistry, CAS between 2002 and 2006.